Form 4: National Healthcare Properties Director Receives Restricted Stock Grant Amidst No Established Market for Shares

A director at National Healthcare Properties, Inc. has acquired 3,110 restricted shares of common stock as compensation, with the company's shares having no established public market and an estimated net asset value of $32.15 per share.

Summary

• Buddie J. Penn, a Director of National Healthcare Properties, Inc., acquired 3,110 shares of the company's common stock on May 23, 2025.
• These shares are restricted stock issued under NHP's 2025 Omnibus Incentive Compensation Plan and will vest on May 22, 2026.
• The acquisition price for these shares was $0, indicating they were granted as compensation.
• Following this transaction, Mr. Penn beneficially owns 7,697 shares of Common Stock directly.
• The company's board of directors approved an estimated per-share net asset value (NAV) of Common Stock of $32.15 as of December 31, 2024.
• There is currently no established market for National Healthcare Properties, Inc.'s Common Stock.
• The number of shares previously owned by the reporting person was adjusted to reflect a four-for-one reverse stock split effected by NHP on September 30, 2024.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of an insider transaction (restricted stock grant). While the grant itself is a positive for the director, the lack of an established market for the stock introduces illiquidity, balancing the overall sentiment to neutral regarding the company's immediate public market prospects.

Positives

• The grant of restricted stock aligns the director's interests with the long-term performance of the company, as the shares vest over time.
• The company's board has established an estimated Net Asset Value (NAV) of $32.15 per share, providing a valuation benchmark for the otherwise illiquid common stock.

Negatives

• There is no established market for the Common Stock, which implies illiquidity for shareholders and makes it difficult to ascertain a true market value.
• The reverse stock split, while a corporate action, can sometimes be perceived negatively by investors if it's done to artificially boost share price or meet listing requirements, though the context here is a private market.

Risks

• The primary risk is the lack of an established market for the Common Stock, which means shareholders may face significant challenges in selling their shares and realizing their value.
• The estimated NAV of $32.15 is an internal valuation and may not reflect the price at which shares could actually be sold, especially given the illiquidity.

Future Outlook

The acquired restricted shares are set to vest on May 22, 2026, indicating a future milestone for the compensation plan.

Management Comments

• The board of directors of NHP approved an estimated per-share net asset value of Common Stock of $32.15 as of December 31, 2024.

Industry Context

This Form 4 filing details an insider transaction (restricted stock grant) for a company that appears to be privately held or not publicly traded on a major exchange, given the 'NONE' ticker and explicit statement of 'no established market for the Common Stock'. This type of compensation is common across various industries for directors and executives, but the illiquidity of the shares is a notable characteristic for this specific entity.

Comparison to Industry Standards

• The grant of restricted stock as compensation is a standard practice for aligning director incentives with company performance, comparable to practices in both public and private companies.
• The lack of an established market for the common stock is a significant deviation from publicly traded healthcare REITs or property companies (e.g., Welltower Inc., Ventas Inc., Healthpeak Properties Inc.), which have liquid shares and transparent market pricing. This makes direct financial performance comparisons difficult.
• The internal estimation of Net Asset Value (NAV) is a common valuation method for private real estate companies or funds, similar to how private equity firms or unlisted REITs might value their assets, but it lacks the independent validation of a public market price.

Corporate Governance

Stakeholder Impact

• Shareholders: The lack of an established market for the common stock means existing shareholders face illiquidity and difficulty in valuing or selling their holdings. The estimated NAV provides an internal valuation, but not a market one.
• Management/Directors: The restricted stock grant serves as a form of compensation and incentive, aligning the director's long-term interests with the company's performance.

Next Steps

• The restricted shares granted to Buddie J. Penn are scheduled to vest on May 22, 2026.

Key Dates

Keywords

National Healthcare Properties, SEC Form 4, Restricted Stock, Director Compensation, Stock Grant, Net Asset Value, Reverse Stock Split, Insider Ownership, Corporate Governance